Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase was written by LaPorte, M. G.;Lessen, T. A.;Leister, L.;Cebzanov, D.;Amparo, E.;Faust, C.;Ortlip, D.;Bailey, T. R.;Nitz, T. J.;Chunduru, S. K.;Young, D. C.;Burns, C. J.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2006.Recommanded Product: 95211-67-9 The following contents are mentioned in the article:
A novel series of selective HCV NS5B RNA dependent RNA polymerase inhibitors has been disclosed. These compounds contain an appropriately substituted tetrahydrobenzothiophene scaffold. This communication will detail the SAR and activities of this series. This study involved multiple reactions and reactants, such as Ethyl 2-amino-4-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (cas: 95211-67-9Recommanded Product: 95211-67-9).
Ethyl 2-amino-4-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (cas: 95211-67-9) belongs to benzothiophene derivatives. Benzothiophene finds use in research as a starting material for the synthesis of larger, usually bioactive structures. The different substitution patterns in these heterocycles offer new opportunities for drug discovery and other applications in materials science.Recommanded Product: 95211-67-9
Referemce:
Benzothiophene – Wikipedia,
Benzothiophene | C8H6S – PubChem